Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma with Dr Matthew Matasar
Dr Matthew Matasar from the Rutgers Cancer Institute of New Jersey in New York, New York, discusses the current and future role of CD20 x CD3 bispecific antibodies in the management of non-Hodgkin lymphoma.
CME information and select publications here
You May Also Like
Real Ghost Stories Online
Real Ghost Stories Online | Paranormal, Supernatural & Horror Radio
Aha! Zehn Minuten Alltags-Wissen
WELT
Ground Truths
Eric Topol
The Grave Talks | Haunted, Paranormal & Supernatural
Ghost Stores, Haunted, Paranormal & Supernatural Stories
That UFO Podcast
That UFO Podcast
The Best of Coast to Coast AM
iHeartPodcasts and Coast to Coast AM
Eye On The Sky
Vermont Public
The Dissenter
Ricardo Lopes
Accès au Marché Mondial des Dispositifs Médicaux
Pure Global
Глобальный доступ на рынок медицинских изделий
Pure Global
Real Ghost Stories Online
Real Ghost Stories Online | Paranormal, Supernatural & Horror Radio
Aha! Zehn Minuten Alltags-Wissen
WELT
Ground Truths
Eric Topol
The Grave Talks | Haunted, Paranormal & Supernatural
Ghost Stores, Haunted, Paranormal & Supernatural Stories
That UFO Podcast
That UFO Podcast
The Best of Coast to Coast AM
iHeartPodcasts and Coast to Coast AM
Eye On The Sky
Vermont Public
The Dissenter
Ricardo Lopes
Accès au Marché Mondial des Dispositifs Médicaux
Pure Global
Глобальный доступ на рынок медицинских изделий
Pure Global
Community discussion